Literature DB >> 11158812

Does cryotherapy affect refractive error? Results from treated versus control eyes in the cryotherapy for retinopathy of prematurity trial.

G E Quinn1, V Dobson, R Siatkowski, R J Hardy, J Kivlin, E A Palmer, D L Phelps, M X Repka, C G Summers, B Tung, W Chan.   

Abstract

PURPOSE: To evaluate the effect of cryotherapy on refractive error status between ages 3 months and 10 years in children with birth weights of less than 1251 g in whom severe retinopathy of prematurity (ROP) developed in one or both eyes during the neonatal period.
DESIGN: Randomized clinical trial. PARTICIPANTS: Two hundred ninety-one children in whom severe ROP developed during the neonatal period. INTERVENTION: Cryotherapy for ROP. MAIN OUTCOME MEASURES: Cycloplegic Refraction
METHODS: The children underwent repeated follow-up eye examinations, including cycloplegic retinoscopy, between 3 months and 10 years after term due date. Refractive error data from all eyes that were randomized to cryotherapy were compared with data from all eyes that were randomized to serve as controls. Refractive error data were also compared for a subset of children who had both a treated and a control eye that could be refracted.
RESULTS: At all ages, the proportion of treated eyes that were unable to be refracted because of retinal detachment, media opacity, or pupillary miosis was approximately half the proportion of the control eyes that were unable to be refracted. When data from all eyes that could be refracted were considered, the distribution of refractive errors between fewer than 8 diopters (D) of myopia and more than 8 D of hyperopia was similar for treated and control eyes at all ages. The proportion of eyes with 8 D or more of myopia was much higher in treated than in control eyes at all ages after 3 months. In the subset of children who had a treated eye and a control eye that could be refracted, distributions of refractive errors in treated versus control eyes were similar at most ages.
CONCLUSIONS: In both treated and control eyes, there was an increase in the prevalence of high myopia between 3 and 12 months of age. Between 12 months and 10 years of age, there was little change in distribution of refractive error in treated or control eyes. The higher prevalence of myopia of 8 D or more in treated eyes, as compared with control eyes, may be the result of cryotherapy's preservation of retinal structure in eyes that, in the absence of cryotherapy, would have progressed to retinal detachment.

Entities:  

Mesh:

Year:  2001        PMID: 11158812     DOI: 10.1016/s0161-6420(00)00527-3

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  26 in total

1.  Refraction and keratometry in 40 week old premature (corrected age) and term infants.

Authors:  M Snir; R Friling; D Weinberger; I Sherf; R Axer-Siegel
Journal:  Br J Ophthalmol       Date:  2004-07       Impact factor: 4.638

2.  Refraction and keratometry in premature infants.

Authors:  M X Repka
Journal:  Br J Ophthalmol       Date:  2004-07       Impact factor: 4.638

3.  Change of refractive state and eye size in children of birth weight less than 1701 g.

Authors:  A R O'Connor; T J Stephenson; A Johnson; M J Tobin; S Ratib; A R Fielder
Journal:  Br J Ophthalmol       Date:  2006-04       Impact factor: 4.638

Review 4.  The neurovascular retina in retinopathy of prematurity.

Authors:  Anne B Fulton; Ronald M Hansen; Anne Moskowitz; James D Akula
Journal:  Prog Retin Eye Res       Date:  2009-06-27       Impact factor: 21.198

5.  Visual outcome and refractive status in first 3 years of age in preterm infants suffered from laser-treated Type 1 retinopathy of prematurity (ROP): a 6-year retrospective review in a tertiary centre in Hong Kong.

Authors:  Julie Y C Lok; Wilson W K Yip; Abbie S W Luk; Joyce K Y Chin; Henry H W Lau; Alvin L Young
Journal:  Int Ophthalmol       Date:  2017-01-04       Impact factor: 2.031

Review 6.  Statement of the German Society of Ophthalmology, the German Retina Society, and the Professional Association of German Ophthalmologists on anti-VEGF therapy of retinopathy of prematurity : Released: 18 May 2020.

Authors: 
Journal:  Ophthalmologe       Date:  2021-01       Impact factor: 1.059

Review 7.  [Statement of the German Ophthalmological Society, the German Retina Society and the Professional Association of German Ophthalmologists on anti-VEGF therapy of retinopathy of prematurity : Released: 18 May 2020].

Authors: 
Journal:  Ophthalmologe       Date:  2020-09       Impact factor: 1.059

Review 8.  [Long-term effects of anti-VEGF therapy for retinopathy of prematurity].

Authors:  T U Krohne; A Müller; P P Larsen; F G Holz
Journal:  Ophthalmologe       Date:  2018-06       Impact factor: 1.059

9.  Astigmatism and biometric optic components of diode laser-treated threshold retinopathy of prematurity at 9 years of age.

Authors:  C-S Yang; A-G Wang; Y-F Shih; W-M Hsu
Journal:  Eye (Lond)       Date:  2012-12-07       Impact factor: 3.775

10.  Astigmatism in the Early Treatment for Retinopathy Of Prematurity Study: findings to 3 years of age.

Authors:  Bradley V Davitt; Velma Dobson; Graham E Quinn; Robert J Hardy; Betty Tung; William V Good
Journal:  Ophthalmology       Date:  2008-12-16       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.